View in EDS PDF Full Text

Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.

Saved in:
Bibliographic Details
Title: Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.
Authors: Barbanti, Piero1,2 (AUTHOR), Aurilia, Cinzia1 (AUTHOR), Filippi, Massimo3 (AUTHOR), Doretti, Alberto4 (AUTHOR), d’Onofrio, Florindo5 (AUTHOR), Scatena, Paola6 (AUTHOR), Vecchio, Rosario7 (AUTHOR), Messina, Roberta3 (AUTHOR), Vinciguerra, Luisa8 (AUTHOR), Ranieri, Angelo9 (AUTHOR), Baldisseri, Francesco10 (AUTHOR), Torelli, Paola11 (AUTHOR), Russo, Marco12 (AUTHOR), Cutrona, Carolina13 (AUTHOR), Viticchi, Giovanna14 (AUTHOR), Egeo, Gabriella1 (AUTHOR), Autunno, Massimo15 (AUTHOR), Pistoia, Francesca16 (AUTHOR), Finocchi, Cinzia17 (AUTHOR), Camarda, Cecilia18 (AUTHOR)
Source: Neurology & Therapy. Jun2026, p1-20. 20p.
Database: Academic Search Ultimate
Description
ISSN:21938253
DOI:10.1007/s40120-026-00971-7